Betaserc (Betahistine) pills

Instructions for Betaserc (Betahistine) pills

English Product Name
Betaserc®

Release Form
Table 8 mg: 30 or 60 pcs.

Description:

Pills of white or almost white color, round, flat, with beveled edges, with engraving "256" on one side.

1 table
betagistina dihydrochloride 8 mg,
which corresponds to betagistin content 5.21 mg
Auxiliaries: cellulose microcrystalline - 80.8 mg, mannitol (E421) - 25 mg, monohydrate lemon acid - 2.5 mg, silicon colloid dioxide - 2.5 mg, talc - 6.3 mg.

15 pcs. - blisters (2) - cardboard packs.
20 pcs. - blisters (3) - cardboard packs.
30 pcs. - blisters (1) - cardboard packs.
30 pcs. - blisters (2) - cardboard packs.

ATX codes
N07CA01 Betahistine

Clinical and pharmacological groups / Group affiliation Betahistine
Drug Betaserc to improve microcirculation of the labyrinth used in pathology of the vestibular apparatus

Active substance Betahistine
betagistina dihydrochloride

Pharmacotherapeutic group Betahistine:

Hystamine drug Betaserc

Indications Betaserc: 

• Meniere Disease;
• Syndromes characterized by dizziness,
• tinnitus and/or progressive hearing loss,
• including internal ear labyrinth water,
• vestibular and labyrinth disorders (including dizziness, noise and pain in the ear) ears,
• headache,
• nausea,
• vomiting,
• hearing loss),
• vestibular neuritis,
• maze, benign positional vertigo (including after neurosurgery);
• Vertebrobasil insufficiency,
• post-traumatic encephalopathy,
• atherosclerosis of brain vessels (as part of comprehensive therapy).

Method of application, course and dosage Betaserc:

One dose - 8-16 mg, intake rate - 3 times/day. Treatment is carried out for a long time.

Drug Interaction:

Antihistamines, when taken simultaneously, reduce the effect of betagistin.

Special Instructions Betahistine:

Use with caution in patients with ulcerative stomach or duodenum disease in the anamnesis, in the II and III trimesters of pregnancy, and in children.
It should be taken into account that the desired clinical effect is achieved after several months of treatment.
In case of dyspeptic symptoms betagistin is recommended to be taken during or after meals.

Child use Betahistine
Use with caution in children.

• Nosology (ICD codes)
• G45.0
• Vertebro-Basilar Arterial System Syndrome
• H81
• Vestibular function violations
• H81.0
• Menera Disease
• H81.1
• Good-quality vapor dizziness
• H81.2
• Vestibular neuronite
• H81.3
• Other peripheral dizziness
• H83.0
• Mazyrintit
• H83.8
• Other specified internal ear diseases
• H90
• Conductive and neurosensory hearing loss
• H93.0
• Degenerative and vascular diseases of the ear
• H93.1
• Tinnitus (subjective)
• I67.2
• Cerebral atherosclerosis
• T90
• Effects of head injuries

Pharmacological effect Betaserc:

Synthetic analog of histamine. It acts like histamine, mainly on histamine H1 receptors. Causes the expansion of the precapillaries, in particular, facilitates microcirculation in the maze. Betagistin also regulates the pressure of the endolymphs in the maze and snail, leading to clinical improvement in dizziness of various etiology. Reduces the frequency and intensity of dizziness, reduces tinnitus, helps to improve hearing in cases of its reduction. Increases the tone of the smooth musculature of the bronchial tubes. May cause increased secretion of the gastric juice.